Tesamorelin 10mg

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview Tesamorelin is a research peptide studied for its relevance to growth hormone pathway modelling metabolic-regulation analysis and peptide–receptor interaction studies. This lyophilized 10 mg preparation supports controlled laboratory evaluation of identity purity and biochemical behaviour.   Peptide Overview From 2010 to 2025 Tesamorelin became an increasingly utilised research compound due to its defined interaction with GH-related pathways and its stable analytical characteristics in in-vitro systems. Its structure allows reproducible modelling of metabolic and endocrine mechanisms.   Historical Background and Scientific Context Scientific interest in GH secretagogue analogues expanded substantially over the past decade as laboratories explored peptides influencing metabolic turnover energy regulation and GH signalling pathways. Tesamorelin developed into a reference compound for metabolic and endocrine pathway modelling.   Mechanistic Focus in Research

• Growth-hormone–related signalling pathway modelling
• Peptide–receptor interaction analysis
• Metabolic-regulation and turnover studies
• Comparative profiling of GH secretagogue peptides
• Controlled in-vitro structure–function evaluation

  Analytical Verification (COA) Independent Liquilabs analysis confirms full validation for Batch GF082025029. Key results include:

• Assay Content: 10.20 mg
• Identification – Retention Time: 1.000
• Identification – Spectrum: 999
• Purity: above 99.8%
• Endotoxins: below 0.001 EU per mg
• Microbial Growth: not detected for aerobic count, yeast or mold
• Heavy Metals: not detected including arsenic cadmium cobalt lead nickel mercury and vanadium

All analytical values were obtained using validated chromatographic spectroscopic and microbiological procedures ensuring full traceability and transparent documentation.   Research Applications

• Growth-hormone pathway modelling
• Metabolic and endocrine regulation studies
• Receptor-binding biochemical experiments
• Comparative GH secretagogue evaluation
• Controlled in-vitro structure–function pathway analysis

 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

• Used in clinical trials involving humans
• Administered to humans as part of an experiment or investigation
• Supplied to another party for human investigational use

• Verified and analysed with Liquilabs s.r.o. Czechia
• Purity above 99.8% with validated assay content
• No detectable heavy metals or microbial contamination
• Endotoxin level below 0.001 EU per mg
• Batch GF082025029 – Published November 2025
• EU shipments include bacteriostatic water
• For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.